Browning MJ, Banks RA, Harrison P, Tribe CR, Fraley CT, Zachary G, et al. Continuous ambulatory peritoneal dialysis in systemic amyloidosis and end-stage renal disease. J R Soc Med. 1984;77:189–92. https://doi.org/10.1177/014107688407700306.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Habuka M, Nishikiori M, Oikawa C, Takahashi M, Sakamaki Y, Ogawa A, et al. Systemic amyloid A amyloidosis Secondary to xanthogranulomatous pyelonephritis. Intern Med. 2024;63:593–9. https://doi.org/10.2169/internalmedicine.1806-23.

Article  PubMed  Google Scholar 

Bollée G, Guery B, Joly D, Snanoudj R, Terrier B, Allouache M, et al. Presentation and outcome of patients with systemic amyloidosis undergoing dialysis. Clin J Am Soc Nephrol. 2008;3:375–81. https://doi.org/10.2215/cjn.02470607.

Article  PubMed  PubMed Central  Google Scholar 

Gertz MA, Kyle RA, O’Fallon WM. Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients. Arch Intern Med. 1992;152:2245–50.

Article  CAS  PubMed  Google Scholar 

Cantaluppi A. CAPD and systemic diseases. Clin Nephrol. 1988;30:S8-12.

PubMed  Google Scholar 

Pinney JH, Lachmann HJ, Bansi L, Wechalekar AD, Gilbertson JA, Rowczenio D, et al. Outcome in renal Al amyloidosis after chemotherapy. J Clin Oncol. 2011;29:674–81. https://doi.org/10.1200/jco.2010.30.5235.

Article  PubMed  Google Scholar 

Anand SK, Sanchorawala V, Verma A. Systemic amyloidosis and kidney transplantation: an update. Semin Nephrol. 2024;44: 151496. https://doi.org/10.1016/j.semnephrol.2024.151496.

Article  CAS  PubMed  Google Scholar 

Nakayama S, Kinugasa S, Hirose T, Miyake Y, Ota K, Onzo-Toyama M, et al. A case of light chain (AL) amyloidosis with heart failure, renal dysfunction, and heparin-induced thrombocytopenia successfully treated with peritoneal dialysis. CEN Case Rep. 2021;10:214–9. https://doi.org/10.1007/s13730-020-00539-w.

Article  PubMed  Google Scholar 

Stofer F, Barretto MF, Gouvea AL, Ribeiro M, Neves M, Gismondi RA, et al. A rare case of ascites due to peritoneal amyloidosis. Am J Case Rep. 2016;17:439–43. https://doi.org/10.12659/ajcr.898357.

Article  PubMed  PubMed Central  Google Scholar 

Berk JL, Keane J, Seldin DC, Sanchorawala V, Koyama J, Dember LM, et al. Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest. 2003;124:969–77. https://doi.org/10.1378/chest.124.3.969.

Article  PubMed  Google Scholar 

Cibeira MT, Sanchorawala V, Seldin DC, Quillen K, Berk JL, Dember LM, et al. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood. 2011;118:4346–52. https://doi.org/10.1182/blood-2011-01-330738.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tanaka T, Naito T, Midori Y, Nosaka T, Takahashi K, Ofuji K, et al. Gastrointestinal AA amyloidosis secondary to chronic pyelonephritis presenting with refractory diarrhea and severe hypoalbuminemia. Clin J Gastroenterol. 2021;14:1642–8. https://doi.org/10.1007/s12328-021-01508-1.

Article  PubMed  Google Scholar 

Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356:2361–71. https://doi.org/10.1056/NEJMoa070265.

Article  CAS  PubMed  Google Scholar 

Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, et al. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int. 1997;51:182–6. https://doi.org/10.1038/ki.1997.22.

Article  CAS  PubMed  Google Scholar 

Rashid G, Korzets Z, Bernheim J. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis. Isr Med Assoc J. 2006;8:36–9.

CAS  PubMed  Google Scholar